# Phase 3 Uterine Cervical cancer trials recruiting: 24 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials in phase 3 for Uterine Cervical cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 Uterine Cervical cancer trials: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/uterine-cervical-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 1, 2026 | NCT07797153 | JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Phase 3 | Not yet recruiting | Recurrent or Metastatic Cervical Cancer | 368 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797153) |
| July 16, 2026 | NCT07709650 | Hypofractionated Chemoradiotherapy for Cervical Cancer | Mahidol University | Phase 3 | Recruiting | Cervival Cancer | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07709650) |
| February 18, 2026 | NCT07418749 | A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor... | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 3 | Recruiting | Recurrent Cervical Cancer, Metastatic Cervical Cancer | 398 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07418749) |
| November 17, 2025 | NCT07230626 | SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer | CSPC Megalith Biopharmaceutical Co.,Ltd. | Phase 3 | Not yet recruiting | Cervical Cancer | 412 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07230626) |
| October 14, 2025 | NCT07216703 | A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Cervical Cancer | 1,023 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216703) |
| September 10, 2025 | NCT07164534 | A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to... | Tata Memorial Hospital | Phase 3 | Not yet recruiting | Uterine Cervical Neoplasm | 316 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07164534) |
| March 11, 2025 | NCT06870565 | Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma | Women's Hospital School Of Medicine Zhejiang University | Phase 3 | Not yet recruiting | Gastric-type Endocervical Adenocarcinoma, Cervical Cancer | 238 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06870565) |
| November 18, 2024 | NCT06692166 | A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer | Mabwell (Shanghai) Bioscience Co., Ltd. | Phase 3 | Recruiting | Cervical Cancer | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06692166) |
| October 15, 2024 | NCT06641635 | Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer | Peking Union Medical College Hospital | Phase 3 | Recruiting | Cervical Cancer, Adaptive Radiotherapy | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06641635) |
| July 19, 2024 | NCT06509724 | Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy | Samsung Medical Center | Phase 3 | Recruiting | Uterine Cervical Neoplasms | 248 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06509724) |
| June 14, 2024 | NCT06459687 | Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer | Lee's Pharmaceutical Limited | Phase 3 | Recruiting | Cervical Cancer | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06459687) |
| March 27, 2024 | NCT06333821 | A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma | Biotech Pharmaceutical Co., Ltd. | Phase 3 | Not yet recruiting | Cervical Cancer | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06333821) |
| March 10, 2023 | NCT05764044 | Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer | Hospital do Coracao | Phase 3 | Recruiting | Cervical Cancer, Cervix Cancer, Cervix Neoplasm | 365 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05764044) |
| February 21, 2023 | NCT05735145 | Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer | Fourth Affiliated Hospital of Guangxi Medical University | Phase 3 | Recruiting | Uterine Cervical Neoplasms, Chemoradiotherapy, Adjuvant Chemotherapy | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05735145) |
| October 14, 2022 | NCT05581121 | PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer | Institut Claudius Regaud | Phase 3 | Recruiting | Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma | 510 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05581121) |
| May 10, 2022 | NCT05367206 | Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III... | Sun Yat-sen University | Phase 3 | Recruiting | Cervical Cancer, Neoadjuvant Chemotherapy, Bulky Neoplasm | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05367206) |
| March 14, 2022 | NCT05277688 | Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients | Ruijin Hospital | Phase 3 | Recruiting | Cervical Cancer | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05277688) |
| December 29, 2021 | NCT05173272 | Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer | Sichuan Cancer Hospital and Research Institute | Phase 3 | Recruiting | Cervical Cancer | 286 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05173272) |
| August 4, 2021 | NCT04989647 | Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy | The Central and Eastern European Gynecologic Oncology Group | Phase 3 | Recruiting | Cervical Cancer | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04989647) |
| July 23, 2021 | NCT04974346 | Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer | Zhejiang Cancer Hospital | Phase 3 | Recruiting | Cervical Cancer | 455 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04974346) |
| February 2, 2021 | NCT04733820 | Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for... | Huazhong University of Science and Technology | Phase 3 | Recruiting | Uterine Cervical Neoplasms, Cervical Cancer | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04733820) |
| June 9, 2020 | NCT04422366 | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 | Recruiting | Cervical Cancer, Vulvar Cancer, Vaginal Cancer, CIN1, CIN2, CIN3, VaIN1, VaIN2, VaIN3, Genital Wart, VIN 1, VIN 2, VIN... | 8,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04422366) |
| February 20, 2019 | NCT03848039 | Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9 | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Cervical Intraepithelial Neoplasia | 1,220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03848039) |
| May 23, 2018 | NCT03534713 | Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread | University Hospital, Toulouse | Phase 3 | Recruiting | Cervical Cancer TNM Staging Regional Lymph Nodes (N) | 310 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03534713) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Sun Yat-sen University | 1 |
| Samsung Medical Center | 1 |
| [Suzhou Suncadia Biopharmaceuticals Co., Ltd.](https://specstream.ai/data/clinical-trials/company/suzhou-suncadia-biopharmaceuticals-co-ltd) | 1 |
| Ruijin Hospital | 1 |
| Tata Memorial Hospital | 1 |
| Mahidol University | 1 |
| Peking Union Medical College Hospital | 1 |
| [Lee's Pharmaceutical Limited](https://specstream.ai/data/clinical-trials/company/lees-pharmaceutical-limited) | 1 |
| Zhejiang Cancer Hospital | 1 |
| Institut Claudius Regaud | 1 |
| University Hospital, Toulouse | 1 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| Fourth Affiliated Hospital of Guangxi Medical University | 1 |
| Sichuan Cancer Hospital and Research Institute | 1 |
| [Mabwell (Shanghai) Bioscience Co., Ltd.](https://specstream.ai/data/clinical-trials/company/mabwell-shanghai-bioscience-co-ltd) | 1 |
| [Jiangsu Alphamab Biopharmaceuticals Co., Ltd](https://specstream.ai/data/clinical-trials/company/jiangsu-alphamab-biopharmaceuticals-co-ltd) | 1 |
| Huazhong University of Science and Technology | 1 |
| [CSPC Megalith Biopharmaceutical Co.,Ltd.](https://specstream.ai/data/clinical-trials/company/cspc-megalith-biopharmaceutical-co-ltd) | 1 |
| Hospital do Coracao | 1 |
| Women's Hospital School Of Medicine Zhejiang University | 1 |
| Shanghai Bovax Biotechnology Co., Ltd. | 1 |
| The Central and Eastern European Gynecologic Oncology Group | 1 |
| Biotech Pharmaceutical Co., Ltd. | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 12 |
| Czechia | 3 |
| France | 3 |
| South Korea | 2 |
| Thailand | 2 |
| Italy | 2 |
| Spain | 2 |
| Brazil | 2 |
| Argentina | 1 |
| Austria | 1 |
| Belgium | 1 |
| Canada | 1 |
| Chile | 1 |
| Colombia | 1 |
| Denmark | 1 |
| Germany | 1 |
| Greece | 1 |
| Hungary | 1 |
| India | 1 |
| Ireland | 1 |
| Israel | 1 |
| Japan | 1 |
| Mexico | 1 |
| Philippines | 1 |
| Poland | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Warehouses in the United States](https://specstream.ai/data/businesses/warehouses/united-states)
- [Water softening equipment suppliers in the United States](https://specstream.ai/data/businesses/water-softening-equipment-suppliers/united-states)
- [Welding companies in the United States](https://specstream.ai/data/businesses/welding-companies/united-states)
- [Wholesale florists in the United States](https://specstream.ai/data/businesses/wholesale-florists/united-states)
- [Window installers in the United States](https://specstream.ai/data/businesses/window-installers/united-states)
- [Wineries in the United States](https://specstream.ai/data/businesses/wineries/united-states)
